

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | L-phenylalanine catabolic process (GO:0006559) | 7.27328940 |
| 2 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 7.27328940 |
| 3 | L-phenylalanine metabolic process (GO:0006558) | 6.99153308 |
| 4 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 6.99153308 |
| 5 | aromatic amino acid family catabolic process (GO:0009074) | 6.44145961 |
| 6 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 6.01292947 |
| 7 | indole-containing compound catabolic process (GO:0042436) | 5.72902926 |
| 8 | indolalkylamine catabolic process (GO:0046218) | 5.72902926 |
| 9 | tryptophan catabolic process (GO:0006569) | 5.72902926 |
| 10 | glyoxylate metabolic process (GO:0046487) | 5.67887401 |
| 11 | kynurenine metabolic process (GO:0070189) | 5.63965132 |
| 12 | bile acid biosynthetic process (GO:0006699) | 5.61790332 |
| 13 | alpha-linolenic acid metabolic process (GO:0036109) | 5.51308545 |
| 14 | tryptophan metabolic process (GO:0006568) | 5.38609419 |
| 15 | cysteine metabolic process (GO:0006534) | 5.36489904 |
| 16 | sulfur amino acid catabolic process (GO:0000098) | 5.30510486 |
| 17 | antigen processing and presentation of endogenous antigen (GO:0019883) | 5.20367900 |
| 18 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 5.15738568 |
| 19 | high-density lipoprotein particle remodeling (GO:0034375) | 5.11519781 |
| 20 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 5.08683840 |
| 21 | positive regulation of gamma-delta T cell activation (GO:0046645) | 5.08172823 |
| 22 | urea metabolic process (GO:0019627) | 5.07861614 |
| 23 | urea cycle (GO:0000050) | 5.07861614 |
| 24 | negative regulation of fibrinolysis (GO:0051918) | 4.95153841 |
| 25 | peptidyl-glutamic acid carboxylation (GO:0017187) | 4.91142398 |
| 26 | protein carboxylation (GO:0018214) | 4.91142398 |
| 27 | serine family amino acid catabolic process (GO:0009071) | 4.89409308 |
| 28 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 4.88400786 |
| 29 | regulation of triglyceride catabolic process (GO:0010896) | 4.84515536 |
| 30 | lysine metabolic process (GO:0006553) | 4.84341604 |
| 31 | lysine catabolic process (GO:0006554) | 4.84341604 |
| 32 | complement activation, alternative pathway (GO:0006957) | 4.79443505 |
| 33 | regulation of fibrinolysis (GO:0051917) | 4.78893032 |
| 34 | bile acid metabolic process (GO:0008206) | 4.77499762 |
| 35 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 4.75959110 |
| 36 | homocysteine metabolic process (GO:0050667) | 4.75401659 |
| 37 | nitrogen cycle metabolic process (GO:0071941) | 4.72632340 |
| 38 | regulation of protein activation cascade (GO:2000257) | 4.70502627 |
| 39 | aromatic amino acid family metabolic process (GO:0009072) | 4.66982654 |
| 40 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 4.66333380 |
| 41 | negative regulation of cell killing (GO:0031342) | 4.66333380 |
| 42 | amino-acid betaine metabolic process (GO:0006577) | 4.61894529 |
| 43 | regulation of cholesterol esterification (GO:0010872) | 4.59582404 |
| 44 | alpha-amino acid catabolic process (GO:1901606) | 4.53985646 |
| 45 | reverse cholesterol transport (GO:0043691) | 4.49194723 |
| 46 | cellular ketone body metabolic process (GO:0046950) | 4.48664220 |
| 47 | tyrosine metabolic process (GO:0006570) | 4.44800225 |
| 48 | protein-lipid complex remodeling (GO:0034368) | 4.41456217 |
| 49 | macromolecular complex remodeling (GO:0034367) | 4.41456217 |
| 50 | plasma lipoprotein particle remodeling (GO:0034369) | 4.41456217 |
| 51 | regulation of complement activation (GO:0030449) | 4.40914417 |
| 52 | coenzyme catabolic process (GO:0009109) | 4.37576723 |
| 53 | acylglycerol homeostasis (GO:0055090) | 4.34200867 |
| 54 | triglyceride homeostasis (GO:0070328) | 4.34200867 |
| 55 | ethanol oxidation (GO:0006069) | 4.32590668 |
| 56 | negative regulation of cholesterol transport (GO:0032375) | 4.26792353 |
| 57 | negative regulation of sterol transport (GO:0032372) | 4.26792353 |
| 58 | cellular glucuronidation (GO:0052695) | 4.25549064 |
| 59 | cellular amino acid catabolic process (GO:0009063) | 4.25329885 |
| 60 | phospholipid efflux (GO:0033700) | 4.22380431 |
| 61 | short-chain fatty acid metabolic process (GO:0046459) | 4.17426655 |
| 62 | plasma lipoprotein particle clearance (GO:0034381) | 4.13273646 |
| 63 | glycine metabolic process (GO:0006544) | 4.09369115 |
| 64 | glutamate metabolic process (GO:0006536) | 4.08624007 |
| 65 | cellular modified amino acid catabolic process (GO:0042219) | 4.08360641 |
| 66 | serine family amino acid metabolic process (GO:0009069) | 4.07566530 |
| 67 | regulation of gamma-delta T cell differentiation (GO:0045586) | 4.05595494 |
| 68 | indolalkylamine metabolic process (GO:0006586) | 4.03326345 |
| 69 | benzene-containing compound metabolic process (GO:0042537) | 4.02159836 |
| 70 | amine catabolic process (GO:0009310) | 4.00434011 |
| 71 | cellular biogenic amine catabolic process (GO:0042402) | 4.00434011 |
| 72 | bile acid and bile salt transport (GO:0015721) | 4.00209890 |
| 73 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 3.95038677 |
| 74 | serine family amino acid biosynthetic process (GO:0009070) | 3.93560692 |
| 75 | regulation of gamma-delta T cell activation (GO:0046643) | 3.93479021 |
| 76 | acetyl-CoA metabolic process (GO:0006084) | 3.92085048 |
| 77 | positive thymic T cell selection (GO:0045059) | 3.88735119 |
| 78 | ketone body metabolic process (GO:1902224) | 3.87941484 |
| 79 | organic acid catabolic process (GO:0016054) | 3.86120145 |
| 80 | carboxylic acid catabolic process (GO:0046395) | 3.86120145 |
| 81 | drug catabolic process (GO:0042737) | 3.85635506 |
| 82 | fatty acid beta-oxidation (GO:0006635) | 3.85635328 |
| 83 | negative T cell selection (GO:0043383) | 3.84945948 |
| 84 | dicarboxylic acid biosynthetic process (GO:0043650) | 3.84851569 |
| 85 | imidazole-containing compound metabolic process (GO:0052803) | 3.84226214 |
| 86 | uronic acid metabolic process (GO:0006063) | 3.83748285 |
| 87 | glucuronate metabolic process (GO:0019585) | 3.83748285 |
| 88 | aspartate family amino acid catabolic process (GO:0009068) | 3.83380475 |
| 89 | negative thymic T cell selection (GO:0045060) | 3.83193063 |
| 90 | immunoglobulin mediated immune response (GO:0016064) | 3.82868713 |
| 91 | cholesterol efflux (GO:0033344) | 3.82345834 |
| 92 | aldehyde catabolic process (GO:0046185) | 3.81762066 |
| 93 | arginine metabolic process (GO:0006525) | 3.77786308 |
| 94 | fatty acid oxidation (GO:0019395) | 3.76673217 |
| 95 | low-density lipoprotein particle remodeling (GO:0034374) | 3.75595762 |
| 96 | monocarboxylic acid catabolic process (GO:0072329) | 3.74437675 |
| 97 | positive regulation of lipoprotein lipase activity (GO:0051006) | 3.73149426 |
| 98 | positive regulation of triglyceride lipase activity (GO:0061365) | 3.73149426 |
| 99 | lipid oxidation (GO:0034440) | 3.71062451 |
| 100 | fatty acid catabolic process (GO:0009062) | 3.69378443 |
| 101 | plasma lipoprotein particle assembly (GO:0034377) | 3.68092613 |
| 102 | neutrophil activation involved in immune response (GO:0002283) | 3.67391219 |
| 103 | negative regulation of lipase activity (GO:0060192) | 3.67217675 |
| 104 | cofactor catabolic process (GO:0051187) | 3.67173375 |
| 105 | 2-oxoglutarate metabolic process (GO:0006103) | 3.67132996 |
| 106 | detection of bacterium (GO:0016045) | 3.64604703 |
| 107 | positive regulation of lipid catabolic process (GO:0050996) | 3.62365386 |
| 108 | response to nitrosative stress (GO:0051409) | 3.62045197 |
| 109 | fibrinolysis (GO:0042730) | 3.61399297 |
| 110 | cholesterol homeostasis (GO:0042632) | 3.58300867 |
| 111 | carnitine metabolic process (GO:0009437) | 3.57567546 |
| 112 | very-low-density lipoprotein particle assembly (GO:0034379) | 3.55959848 |
| 113 | detection of other organism (GO:0098543) | 3.54393525 |
| 114 | phospholipid homeostasis (GO:0055091) | 3.53325288 |
| 115 | regulation of B cell receptor signaling pathway (GO:0050855) | 3.52554466 |
| 116 | sterol homeostasis (GO:0055092) | 3.52299915 |
| 117 | regulation of bile acid biosynthetic process (GO:0070857) | 3.51073555 |
| 118 | flavonoid metabolic process (GO:0009812) | 3.47489481 |
| 119 | positive regulation of B cell differentiation (GO:0045579) | 3.33141491 |
| 120 | positive T cell selection (GO:0043368) | 3.31216861 |
| 121 | leukocyte aggregation (GO:0070486) | 3.21084646 |
| 122 | thymic T cell selection (GO:0045061) | 3.20695539 |
| 123 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 3.19667299 |
| 124 | T cell selection (GO:0045058) | 3.19653472 |
| 125 | regulation of T cell tolerance induction (GO:0002664) | 3.17397102 |
| 126 | type I interferon signaling pathway (GO:0060337) | 3.14431224 |
| 127 | cellular response to type I interferon (GO:0071357) | 3.14431224 |
| 128 | response to type I interferon (GO:0034340) | 3.12628186 |
| 129 | T cell migration (GO:0072678) | 3.12105018 |
| 130 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 3.11321762 |
| 131 | response to interleukin-15 (GO:0070672) | 3.09694791 |
| 132 | regulation of regulatory T cell differentiation (GO:0045589) | 3.06979882 |
| 133 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 3.06509685 |
| 134 | antigen processing and presentation via MHC class Ib (GO:0002475) | 3.04025168 |
| 135 | response to interferon-beta (GO:0035456) | 3.03311752 |
| 136 | regulation of tolerance induction (GO:0002643) | 3.03120361 |
| 137 | regulation of T cell mediated cytotoxicity (GO:0001914) | 3.00128138 |
| 138 | positive regulation of T cell mediated cytotoxicity (GO:0001916) | 2.99620562 |
| 139 | tolerance induction (GO:0002507) | 2.99013990 |
| 140 | negative regulation of leukocyte mediated immunity (GO:0002704) | 2.96810653 |
| 141 | regulation of antigen processing and presentation (GO:0002577) | 2.96263622 |
| 142 | positive regulation of antigen processing and presentation (GO:0002579) | 2.95173838 |
| 143 | interferon-gamma-mediated signaling pathway (GO:0060333) | 2.93586449 |
| 144 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 2.92865607 |
| 145 | cellular response to interleukin-15 (GO:0071350) | 2.90553661 |
| 146 | regulation of B cell differentiation (GO:0045577) | 2.89629844 |
| 147 | B cell mediated immunity (GO:0019724) | 2.89383006 |
| 148 | regulation of alpha-beta T cell proliferation (GO:0046640) | 2.88456990 |
| 149 | positive regulation of tolerance induction (GO:0002645) | 2.84485339 |
| 150 | positive regulation by symbiont of host defense response (GO:0052509) | 2.80974605 |
| 151 | modulation by symbiont of host defense response (GO:0052031) | 2.80974605 |
| 152 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 2.80974605 |
| 153 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 2.80974605 |
| 154 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 2.80974605 |
| 155 | modulation by symbiont of host immune response (GO:0052553) | 2.80974605 |
| 156 | detection of external biotic stimulus (GO:0098581) | 2.80300959 |
| 157 | negative regulation of erythrocyte differentiation (GO:0045647) | 2.79636689 |
| 158 | B cell receptor signaling pathway (GO:0050853) | 2.79322360 |
| 159 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 2.79272629 |
| 160 | neutrophil activation (GO:0042119) | 2.78920600 |
| 161 | negative regulation of innate immune response (GO:0045824) | 2.78778359 |
| 162 | negative regulation of T cell mediated immunity (GO:0002710) | 2.78093480 |
| 163 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 2.76615353 |
| 164 | response to peptidoglycan (GO:0032494) | 2.70257292 |
| 165 | cellular extravasation (GO:0045123) | 2.69993367 |
| 166 | positive regulation of granulocyte differentiation (GO:0030854) | 2.69675678 |
| 167 | regulation of natural killer cell mediated immunity (GO:0002715) | 2.66193177 |
| 168 | regulation of natural killer cell mediated cytotoxicity (GO:0042269) | 2.66193177 |
| 169 | negative regulation of interleukin-12 production (GO:0032695) | 2.63951692 |
| 170 | macrophage activation involved in immune response (GO:0002281) | 2.63769120 |
| 171 | mature B cell differentiation involved in immune response (GO:0002313) | 2.61740105 |
| 172 | myeloid cell activation involved in immune response (GO:0002275) | 2.61226704 |
| 173 | regulation of leukocyte mediated cytotoxicity (GO:0001910) | 2.59226211 |
| 174 | antigen receptor-mediated signaling pathway (GO:0050851) | 2.56849311 |
| 175 | granulocyte activation (GO:0036230) | 2.56757615 |
| 176 | cytidine deamination (GO:0009972) | 2.55576444 |
| 177 | cytidine metabolic process (GO:0046087) | 2.55576444 |
| 178 | cytidine catabolic process (GO:0006216) | 2.55576444 |
| 179 | positive regulation of leukocyte mediated cytotoxicity (GO:0001912) | 2.55458531 |
| 180 | mast cell activation (GO:0045576) | 2.54466841 |
| 181 | T cell receptor signaling pathway (GO:0050852) | 2.51711051 |
| 182 | negative regulation of cytokine production involved in immune response (GO:0002719) | 2.50960491 |
| 183 | T cell costimulation (GO:0031295) | 2.50915908 |
| 184 | regulation of interleukin-2 biosynthetic process (GO:0045076) | 2.48577671 |
| 185 | detection of biotic stimulus (GO:0009595) | 2.47736850 |
| 186 | lymphocyte costimulation (GO:0031294) | 2.46975120 |
| 187 | leukocyte degranulation (GO:0043299) | 2.46115363 |
| 188 | respiratory burst (GO:0045730) | 2.45624826 |
| 189 | autophagic vacuole fusion (GO:0000046) | 2.44467053 |
| 190 | dendritic cell chemotaxis (GO:0002407) | 2.43563388 |
| 191 | activated T cell proliferation (GO:0050798) | 2.43281683 |
| 192 | regulation of mast cell degranulation (GO:0043304) | 2.43259274 |
| 193 | lymphocyte chemotaxis (GO:0048247) | 2.40143294 |
| 194 | cellular response to interferon-beta (GO:0035458) | 2.38975382 |
| 195 | defense response to protozoan (GO:0042832) | 2.36849400 |
| 196 | regulation of interferon-beta biosynthetic process (GO:0045357) | 2.33574801 |
| 197 | pyrimidine ribonucleoside catabolic process (GO:0046133) | 2.33473350 |
| 198 | positive regulation of alpha-beta T cell proliferation (GO:0046641) | 2.32541488 |
| 199 | regulation of cell killing (GO:0031341) | 2.31787490 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 7.94554949 |
| 2 | * PPARA_22158963_ChIP-Seq_LIVER_Mouse | 6.82513747 |
| 3 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 6.47866489 |
| 4 | * LXR_22158963_ChIP-Seq_LIVER_Mouse | 6.15377028 |
| 5 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 5.70142473 |
| 6 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 5.06978937 |
| 7 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 4.79067367 |
| 8 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 4.70852635 |
| 9 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 3.75069718 |
| 10 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 3.60107860 |
| 11 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 3.31943014 |
| 12 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 3.02712729 |
| 13 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 2.94808429 |
| 14 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.72957605 |
| 15 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 2.46931348 |
| 16 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.41234208 |
| 17 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 2.40374843 |
| 18 | RUNX_20019798_ChIP-Seq_JUKART_Human | 2.34041375 |
| 19 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.25595853 |
| 20 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.23776403 |
| 21 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.22066276 |
| 22 | MYB_26560356_Chip-Seq_TH2_Human | 2.19455373 |
| 23 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 2.13245039 |
| 24 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 2.10928606 |
| 25 | MAF_26560356_Chip-Seq_TH1_Human | 2.06317745 |
| 26 | VDR_24763502_ChIP-Seq_THP-1_Human | 2.06100386 |
| 27 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.02089443 |
| 28 | SPI1_23547873_ChIP-Seq_NB4_Human | 2.01047147 |
| 29 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 11.3466750 |
| 30 | * HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.98146134 |
| 31 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.93409957 |
| 32 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.93376841 |
| 33 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.91093877 |
| 34 | UTX_26944678_Chip-Seq_JUKART_Human | 1.90692678 |
| 35 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.86440840 |
| 36 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.85920532 |
| 37 | MYB_26560356_Chip-Seq_TH1_Human | 1.83602754 |
| 38 | SPI1_23127762_ChIP-Seq_K562_Human | 1.82862961 |
| 39 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.82690730 |
| 40 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.80556756 |
| 41 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.77781268 |
| 42 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.77043768 |
| 43 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.73723059 |
| 44 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.68650079 |
| 45 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.67820440 |
| 46 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.64901127 |
| 47 | MAF_26560356_Chip-Seq_TH2_Human | 1.62763807 |
| 48 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.60731673 |
| 49 | GATA1_22025678_ChIP-Seq_K562_Human | 1.56628004 |
| 50 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.56123755 |
| 51 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.53220297 |
| 52 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.52224473 |
| 53 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.49960874 |
| 54 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.49541659 |
| 55 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.45581315 |
| 56 | * GATA3_27048872_Chip-Seq_THYMUS_Human | 1.45456294 |
| 57 | MYC_22102868_ChIP-Seq_BL_Human | 1.40317766 |
| 58 | * CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.36402352 |
| 59 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.36285750 |
| 60 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.33904990 |
| 61 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.33238237 |
| 62 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.31184629 |
| 63 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.30899104 |
| 64 | HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.29562861 |
| 65 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.29253486 |
| 66 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.29116328 |
| 67 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.28896412 |
| 68 | * PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.26567333 |
| 69 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.25510988 |
| 70 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.25440744 |
| 71 | GATA3_26560356_Chip-Seq_TH2_Human | 1.24121494 |
| 72 | * CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.22995207 |
| 73 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.22709522 |
| 74 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.22514196 |
| 75 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.21381720 |
| 76 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.20187251 |
| 77 | * PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.19718330 |
| 78 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.19466033 |
| 79 | * CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.13706808 |
| 80 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.13208478 |
| 81 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.12681900 |
| 82 | * PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.10825862 |
| 83 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.10756013 |
| 84 | * SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.10496818 |
| 85 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.10004790 |
| 86 | P300_27268052_Chip-Seq_Bcells_Human | 1.09236121 |
| 87 | STAT1_20625510_ChIP-Seq_HELA_Human | 1.07832810 |
| 88 | RXRA_24833708_ChIP-Seq_LIVER_Mouse | 1.07427248 |
| 89 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.04944221 |
| 90 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.04696733 |
| 91 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.04145581 |
| 92 | * VDR_24787735_ChIP-Seq_THP-1_Human | 1.03940144 |
| 93 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.03476897 |
| 94 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.03251237 |
| 95 | P68_20966046_ChIP-Seq_HELA_Human | 1.02469080 |
| 96 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.00661923 |
| 97 | SPI1_20517297_ChIP-Seq_HL60_Human | 0.99730543 |
| 98 | GATA4_25053715_ChIP-Seq_YYC3_Human | 0.98248858 |
| 99 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 0.97836145 |
| 100 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 0.95400593 |
| 101 | SA1_27219007_Chip-Seq_Bcells_Human | 0.95099351 |
| 102 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 0.95017661 |
| 103 | E2F1_20622854_ChIP-Seq_HELA_Human | 0.94470184 |
| 104 | CTCF_26484167_Chip-Seq_Bcells_Mouse | 0.92582752 |
| 105 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 0.91762333 |
| 106 | AUTS2_25519132_ChIP-Seq_293T-REX_Human | 0.90431747 |
| 107 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.89602171 |
| 108 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 0.89524448 |
| 109 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 0.88715890 |
| 110 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 0.88474412 |
| 111 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.87060068 |
| 112 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 0.85343656 |
| 113 | ZNF263_19887448_ChIP-Seq_K562_Human | 0.82103973 |
| 114 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.79012236 |
| 115 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.79012236 |
| 116 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 0.78321484 |
| 117 | * AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.77892109 |
| 118 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.77462112 |
| 119 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.76393374 |
| 120 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 0.75981687 |
| 121 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 0.74722074 |
| 122 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 0.73825833 |
| 123 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 0.72972257 |
| 124 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 0.72802524 |
| 125 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 0.70402642 |
| 126 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 0.69244912 |
| 127 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 0.69127781 |
| 128 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 0.68215096 |
| 129 | CEBPB_22108803_ChIP-Seq_LS180_Human | 0.65914809 |
| 130 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 0.65805150 |
| 131 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 0.64595750 |
| 132 | KAP1_22055183_ChIP-Seq_ESCs_Mouse | 0.63722026 |
| 133 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.63623214 |
| 134 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 0.63098061 |
| 135 | AR_20517297_ChIP-Seq_VCAP_Human | 0.62507300 |
| 136 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 0.62427705 |
| 137 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.61796046 |
| 138 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 0.60349313 |
| 139 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.59573164 |
| 140 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.59176501 |
| 141 | RARA_24833708_ChIP-Seq_LIVER_Mouse | 0.58323445 |
| 142 | FOXA1_25552417_ChIP-Seq_VCAP_Human | 0.58170295 |
| 143 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.57753187 |
| 144 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 0.56937649 |
| 145 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 0.56313439 |
| 146 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 0.56313439 |
| 147 | RARB_24833708_ChIP-Seq_LIVER_Mouse | 0.53993077 |
| 148 | CBP_21632823_ChIP-Seq_H3396_Human | 0.52825886 |
| 149 | SOX2_20726797_ChIP-Seq_SW620_Human | 0.52795190 |
| 150 | PPARG_20887899_ChIP-Seq_3T3-L1_Mouse | 0.52682908 |
| 151 | ESET_19884257_ChIP-Seq_ESCs_Mouse | 0.51731548 |
| 152 | P53_21459846_ChIP-Seq_SAOS-2_Human | 0.51536694 |
| 153 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.49609849 |
| 154 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 0.49476977 |
| 155 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.49297673 |
| 156 | GATA1_19941826_ChIP-Seq_K562_Human | 0.48878249 |
| 157 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 0.48741868 |
| 158 | TAF2_19829295_ChIP-Seq_ESCs_Human | 0.48319916 |
| 159 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 0.48212561 |
| 160 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.47838924 |
| 161 | MYC_19915707_ChIP-ChIP_AK7_Human | 0.47572884 |
| 162 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 0.46869480 |
| 163 | GATA2_19941826_ChIP-Seq_K562_Human | 0.46545215 |
| 164 | FOXA1_26743006_Chip-Seq_LNCaP-abl_Human | 0.45848212 |
| 165 | GATA6_25053715_ChIP-Seq_YYC3_Human | 0.45409323 |
| 166 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.45362184 |
| 167 | GATA3_24758297_ChIP-Seq_MCF-7_Human | 0.44960098 |
| 168 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 0.44316718 |
| 169 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 0.44076347 |
| 170 | ERG_20517297_ChIP-Seq_VCAP_Human | 0.43449149 |
| 171 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.43130138 |
| 172 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.42044020 |
| 173 | CSB_26484114_Chip-Seq_FIBROBLAST_Human | 0.41749654 |
| 174 | * STAT1_17558387_ChIP-Seq_HELA_Human | 0.41528171 |
| 175 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 0.41446442 |
| 176 | STAT3_19079543_ChIP-ChIP_MESCs_Mouse | 0.40631071 |
| 177 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.40006280 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002139_abnormal_hepatobiliary_system | 7.89140761 |
| 2 | MP0005360_urolithiasis | 7.22023758 |
| 3 | MP0005085_abnormal_gallbladder_physiolo | 6.11670634 |
| 4 | MP0005365_abnormal_bile_salt | 5.94216681 |
| 5 | MP0008875_abnormal_xenobiotic_pharmacok | 5.00657492 |
| 6 | MP0003806_abnormal_nucleotide_metabolis | 4.40756424 |
| 7 | MP0003252_abnormal_bile_duct | 3.66461355 |
| 8 | MP0010329_abnormal_lipoprotein_level | 3.48051563 |
| 9 | MP0001835_abnormal_antigen_presentation | 3.44896701 |
| 10 | MP0009840_abnormal_foam_cell | 3.26140873 |
| 11 | MP0003436_decreased_susceptibility_to | 3.23239761 |
| 12 | MP0005671_abnormal_response_to | 3.04471571 |
| 13 | MP0005083_abnormal_biliary_tract | 3.04044811 |
| 14 | MP0005332_abnormal_amino_acid | 2.90655721 |
| 15 | MP0001666_abnormal_nutrient_absorption | 2.78617650 |
| 16 | MP0003195_calcinosis | 2.71572206 |
| 17 | MP0009785_altered_susceptibility_to | 2.59992383 |
| 18 | MP0005025_abnormal_response_to | 2.56968940 |
| 19 | MP0001800_abnormal_humoral_immune | 2.56737138 |
| 20 | MP0005000_abnormal_immune_tolerance | 2.53845409 |
| 21 | MP0003763_abnormal_thymus_physiology | 2.51897342 |
| 22 | MP0005387_immune_system_phenotype | 2.44776172 |
| 23 | MP0001790_abnormal_immune_system | 2.44776172 |
| 24 | MP0000685_abnormal_immune_system | 2.43475947 |
| 25 | MP0002419_abnormal_innate_immunity | 2.39863075 |
| 26 | MP0002148_abnormal_hypersensitivity_rea | 2.33236979 |
| 27 | MP0002723_abnormal_immune_serum | 2.26909565 |
| 28 | MP0003191_abnormal_cellular_cholesterol | 2.19538004 |
| 29 | MP0002118_abnormal_lipid_homeostasis | 2.15853206 |
| 30 | MP0002452_abnormal_antigen_presenting | 2.15767517 |
| 31 | MP0002420_abnormal_adaptive_immunity | 2.15352647 |
| 32 | MP0003303_peritoneal_inflammation | 2.14206515 |
| 33 | MP0006082_CNS_inflammation | 2.14195010 |
| 34 | MP0010155_abnormal_intestine_physiology | 2.13596822 |
| 35 | MP0001819_abnormal_immune_cell | 2.13263793 |
| 36 | MP0004019_abnormal_vitamin_homeostasis | 2.10241886 |
| 37 | MP0009333_abnormal_splenocyte_physiolog | 2.08150112 |
| 38 | MP0000609_abnormal_liver_physiology | 2.03808927 |
| 39 | MP0002138_abnormal_hepatobiliary_system | 1.89775740 |
| 40 | MP0005319_abnormal_enzyme/_coenzyme | 1.83388657 |
| 41 | MP0003868_abnormal_feces_composition | 1.80317512 |
| 42 | MP0003866_abnormal_defecation | 1.78996667 |
| 43 | MP0001845_abnormal_inflammatory_respons | 1.73236147 |
| 44 | MP0001533_abnormal_skeleton_physiology | 1.67900788 |
| 45 | MP0003300_gastrointestinal_ulcer | 1.65738926 |
| 46 | MP0000465_gastrointestinal_hemorrhage | 1.65095095 |
| 47 | MP0000716_abnormal_immune_system | 1.64051842 |
| 48 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.63542027 |
| 49 | MP0002398_abnormal_bone_marrow | 1.62416399 |
| 50 | MP0005451_abnormal_body_composition | 1.61774440 |
| 51 | MP0002405_respiratory_system_inflammati | 1.58963419 |
| 52 | MP0001764_abnormal_homeostasis | 1.58053455 |
| 53 | MP0004947_skin_inflammation | 1.55227350 |
| 54 | MP0003186_abnormal_redox_activity | 1.53857369 |
| 55 | MP0001873_stomach_inflammation | 1.51820609 |
| 56 | MP0003011_delayed_dark_adaptation | 1.43591104 |
| 57 | MP0002166_altered_tumor_susceptibility | 1.42963430 |
| 58 | MP0000689_abnormal_spleen_morphology | 1.40854347 |
| 59 | MP0009643_abnormal_urine_homeostasis | 1.40825592 |
| 60 | MP0009697_abnormal_copulation | 1.39397213 |
| 61 | MP0002722_abnormal_immune_system | 1.34691484 |
| 62 | MP0002429_abnormal_blood_cell | 1.31382236 |
| 63 | MP0003183_abnormal_peptide_metabolism | 1.27696634 |
| 64 | MP0003172_abnormal_lysosome_physiology | 1.23721256 |
| 65 | MP0002396_abnormal_hematopoietic_system | 1.22375110 |
| 66 | MP0003656_abnormal_erythrocyte_physiolo | 1.22042560 |
| 67 | MP0000858_altered_metastatic_potential | 1.17828826 |
| 68 | MP0006036_abnormal_mitochondrial_physio | 1.14363898 |
| 69 | MP0001851_eye_inflammation | 1.13952113 |
| 70 | MP0004130_abnormal_muscle_cell | 1.12034348 |
| 71 | MP0002933_joint_inflammation | 1.10728425 |
| 72 | MP0000703_abnormal_thymus_morphology | 1.10704692 |
| 73 | MP0009278_abnormal_bone_marrow | 1.09766555 |
| 74 | MP0005397_hematopoietic_system_phenotyp | 1.09422008 |
| 75 | MP0001545_abnormal_hematopoietic_system | 1.09422008 |
| 76 | MP0005647_abnormal_sex_gland | 1.09413481 |
| 77 | MP0010368_abnormal_lymphatic_system | 1.09261781 |
| 78 | MP0003828_pulmonary_edema | 1.08103075 |
| 79 | MP0000598_abnormal_liver_morphology | 1.07015309 |
| 80 | MP0003705_abnormal_hypodermis_morpholog | 1.06068620 |
| 81 | MP0002837_dystrophic_cardiac_calcinosis | 1.04490030 |
| 82 | MP0008260_abnormal_autophagy | 1.04234333 |
| 83 | MP0005670_abnormal_white_adipose | 1.03245326 |
| 84 | MP0005636_abnormal_mineral_homeostasis | 1.00187671 |
| 85 | MP0002254_reproductive_system_inflammat | 0.97973938 |
| 86 | MP0000604_amyloidosis | 0.97791226 |
| 87 | MP0009764_decreased_sensitivity_to | 0.97662972 |
| 88 | MP0009763_increased_sensitivity_to | 0.94948286 |
| 89 | MP0002998_abnormal_bone_remodeling | 0.93195025 |
| 90 | MP0005084_abnormal_gallbladder_morpholo | 0.92440957 |
| 91 | MP0000343_altered_response_to | 0.91006266 |
| 92 | MP0001663_abnormal_digestive_system | 0.90266297 |
| 93 | MP0005075_abnormal_melanosome_morpholog | 0.89814242 |
| 94 | MP0003690_abnormal_glial_cell | 0.86783379 |
| 95 | MP0002006_tumorigenesis | 0.86410332 |
| 96 | MP0005164_abnormal_response_to | 0.86115998 |
| 97 | MP0004883_abnormal_blood_vessel | 0.86020441 |
| 98 | MP0009642_abnormal_blood_homeostasis | 0.85465423 |
| 99 | MP0008469_abnormal_protein_level | 0.84410413 |
| 100 | MP0004510_myositis | 0.84079604 |
| 101 | MP0005408_hypopigmentation | 0.83467316 |
| 102 | MP0002971_abnormal_brown_adipose | 0.83207485 |
| 103 | MP0005310_abnormal_salivary_gland | 0.83083699 |
| 104 | MP0005376_homeostasis/metabolism_phenot | 0.80925936 |
| 105 | MP0002078_abnormal_glucose_homeostasis | 0.79680923 |
| 106 | MP0003045_fibrosis | 0.77834981 |
| 107 | MP0005666_abnormal_adipose_tissue | 0.76039389 |
| 108 | MP0003448_altered_tumor_morphology | 0.74955328 |
| 109 | MP0005266_abnormal_metabolism | 0.74820562 |
| 110 | MP0005535_abnormal_body_temperature | 0.73625754 |
| 111 | MP0005334_abnormal_fat_pad | 0.72723463 |
| 112 | MP0009765_abnormal_xenobiotic_induced | 0.71833901 |
| 113 | MP0005220_abnormal_exocrine_pancreas | 0.71013192 |
| 114 | MP0002876_abnormal_thyroid_physiology | 0.70895305 |
| 115 | MP0001661_extended_life_span | 0.70430610 |
| 116 | MP0001756_abnormal_urination | 0.67681632 |
| 117 | MP0003329_amyloid_beta_deposits | 0.66835560 |
| 118 | MP0004043_abnormal_pH_regulation | 0.64743409 |
| 119 | MP0006035_abnormal_mitochondrial_morpho | 0.61603973 |
| 120 | MP0004782_abnormal_surfactant_physiolog | 0.60170446 |
| 121 | MP0002136_abnormal_kidney_physiology | 0.55146219 |
| 122 | MP0005448_abnormal_energy_balance | 0.54646458 |
| 123 | MP0003724_increased_susceptibility_to | 0.50322729 |
| 124 | MP0009053_abnormal_anal_canal | 0.50118810 |
| 125 | MP0003638_abnormal_response/metabolism_ | 0.49785284 |
| 126 | MP0000230_abnormal_systemic_arterial | 0.48830823 |
| 127 | MP0003075_altered_response_to | 0.48341829 |
| 128 | MP0002796_impaired_skin_barrier | 0.47783144 |
| 129 | MP0005330_cardiomyopathy | 0.47641882 |
| 130 | MP0009384_cardiac_valve_regurgitation | 0.47568929 |
| 131 | MP0000639_abnormal_adrenal_gland | 0.47349442 |
| 132 | MP0003953_abnormal_hormone_level | 0.41160387 |
| 133 | MP0008874_decreased_physiological_sensi | 0.40787815 |
| 134 | MP0001853_heart_inflammation | 0.40535917 |
| 135 | MP0004381_abnormal_hair_follicle | 0.39235623 |
| 136 | MP0005165_increased_susceptibility_to | 0.38954148 |
| 137 | MP0002822_catalepsy | 0.38907525 |
| 138 | MP0005464_abnormal_platelet_physiology | 0.38651775 |
| 139 | MP0004185_abnormal_adipocyte_glucose | 0.38092419 |
| 140 | MP0008873_increased_physiological_sensi | 0.37836345 |
| 141 | MP0009115_abnormal_fat_cell | 0.37154080 |
| 142 | MP0005395_other_phenotype | 0.36941584 |
| 143 | MP0000249_abnormal_blood_vessel | 0.36202342 |
| 144 | MP0004147_increased_porphyrin_level | 0.36094694 |
| 145 | MP0000579_abnormal_nail_morphology | 0.36034582 |
| 146 | MP0005166_decreased_susceptibility_to | 0.35944002 |
| 147 | MP0005058_abnormal_lysosome_morphology | 0.35608387 |
| 148 | MP0002295_abnormal_pulmonary_circulatio | 0.35394250 |
| 149 | MP0005167_abnormal_blood-brain_barrier | 0.35006190 |
| 150 | MP0002269_muscular_atrophy | 0.34925686 |
| 151 | MP0002928_abnormal_bile_duct | 0.34657894 |
| 152 | MP0003646_muscle_fatigue | 0.33030340 |
| 153 | MP0001765_abnormal_ion_homeostasis | 0.32515129 |
| 154 | MP0003718_maternal_effect | 0.32316007 |
| 155 | MP0002970_abnormal_white_adipose | 0.29849951 |
| 156 | MP0005595_abnormal_vascular_smooth | 0.29767814 |
| 157 | MP0009672_abnormal_birth_weight | 0.29146499 |
| 158 | MP0002132_abnormal_respiratory_system | 0.27276967 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 7.00642103 |
| 2 | Intrahepatic cholestasis (HP:0001406) | 6.74827110 |
| 3 | Deep venous thrombosis (HP:0002625) | 6.61727207 |
| 4 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 6.00841732 |
| 5 | Xanthomatosis (HP:0000991) | 5.91380540 |
| 6 | Hypobetalipoproteinemia (HP:0003563) | 5.88889715 |
| 7 | Prolonged partial thromboplastin time (HP:0003645) | 5.85767332 |
| 8 | Hyperlipoproteinemia (HP:0010980) | 5.40882013 |
| 9 | Hyperammonemia (HP:0001987) | 4.79567062 |
| 10 | Elevated erythrocyte sedimentation rate (HP:0003565) | 4.73541804 |
| 11 | Complement deficiency (HP:0004431) | 4.71031717 |
| 12 | Hyperglycinemia (HP:0002154) | 4.66998810 |
| 13 | Eczematoid dermatitis (HP:0000976) | 4.66759691 |
| 14 | Ketosis (HP:0001946) | 4.58301533 |
| 15 | Hyperglycinuria (HP:0003108) | 4.53373819 |
| 16 | Hypolipoproteinemia (HP:0010981) | 4.52395235 |
| 17 | Abnormality of serine family amino acid metabolism (HP:0010894) | 4.45893944 |
| 18 | Abnormality of glycine metabolism (HP:0010895) | 4.45893944 |
| 19 | Myositis (HP:0100614) | 4.30624337 |
| 20 | Hypoglycemic coma (HP:0001325) | 4.20848178 |
| 21 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 4.18889020 |
| 22 | Joint hemorrhage (HP:0005261) | 4.17108291 |
| 23 | Epidermoid cyst (HP:0200040) | 4.07501397 |
| 24 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 4.04091280 |
| 25 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 4.04068541 |
| 26 | Hypoalphalipoproteinemia (HP:0003233) | 4.02962761 |
| 27 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 3.98841831 |
| 28 | Recurrent abscess formation (HP:0002722) | 3.98841211 |
| 29 | Abnormality of methionine metabolism (HP:0010901) | 3.96237434 |
| 30 | Fat malabsorption (HP:0002630) | 3.95308864 |
| 31 | Abnormality of the common coagulation pathway (HP:0010990) | 3.87308745 |
| 32 | Abnormality of fatty-acid metabolism (HP:0004359) | 3.81689486 |
| 33 | Recurrent bacterial skin infections (HP:0005406) | 3.79629193 |
| 34 | Abnormality of macrophages (HP:0004311) | 3.77130212 |
| 35 | Stomatitis (HP:0010280) | 3.74661581 |
| 36 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 3.62370159 |
| 37 | Ketoacidosis (HP:0001993) | 3.61791111 |
| 38 | Recurrent gram-negative bacterial infections (HP:0005420) | 3.52591209 |
| 39 | Abnormality of the intrinsic pathway (HP:0010989) | 3.44252508 |
| 40 | Recurrent fungal infections (HP:0002841) | 3.43246759 |
| 41 | Orchitis (HP:0100796) | 3.41783556 |
| 42 | Abnormality of complement system (HP:0005339) | 3.37389346 |
| 43 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 3.33439500 |
| 44 | Obstructive lung disease (HP:0006536) | 3.30804797 |
| 45 | Chronic obstructive pulmonary disease (HP:0006510) | 3.30804797 |
| 46 | Hypercholesterolemia (HP:0003124) | 3.29193863 |
| 47 | Meningitis (HP:0001287) | 3.27734157 |
| 48 | Abnormality of pyrimidine metabolism (HP:0004353) | 3.24837888 |
| 49 | Conjugated hyperbilirubinemia (HP:0002908) | 3.23733806 |
| 50 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 3.19750514 |
| 51 | Dicarboxylic aciduria (HP:0003215) | 3.19750514 |
| 52 | Delayed CNS myelination (HP:0002188) | 3.19033888 |
| 53 | Abnormality of serum amino acid levels (HP:0003112) | 3.19011044 |
| 54 | Optic neuritis (HP:0100653) | 3.15849742 |
| 55 | Retrobulbar optic neuritis (HP:0100654) | 3.15849742 |
| 56 | Hyperbilirubinemia (HP:0002904) | 3.10905189 |
| 57 | Steatorrhea (HP:0002570) | 3.10888267 |
| 58 | Pustule (HP:0200039) | 3.06637906 |
| 59 | Metabolic acidosis (HP:0001942) | 3.03628279 |
| 60 | T lymphocytopenia (HP:0005403) | 3.03175491 |
| 61 | Petechiae (HP:0000967) | 2.97485507 |
| 62 | Abnormality of T cell number (HP:0011839) | 2.96239870 |
| 63 | Abnormality of nucleobase metabolism (HP:0010932) | 2.95552027 |
| 64 | Lethargy (HP:0001254) | 2.94329283 |
| 65 | Gastrointestinal infarctions (HP:0005244) | 2.94264843 |
| 66 | Recurrent cutaneous fungal infections (HP:0011370) | 2.94136797 |
| 67 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.94136797 |
| 68 | Panhypogammaglobulinemia (HP:0003139) | 2.93769615 |
| 69 | Recurrent skin infections (HP:0001581) | 2.93053448 |
| 70 | Vasculitis (HP:0002633) | 2.90206710 |
| 71 | Cerebral edema (HP:0002181) | 2.88024121 |
| 72 | Mediastinal lymphadenopathy (HP:0100721) | 2.87425339 |
| 73 | Prolonged bleeding time (HP:0003010) | 2.86074420 |
| 74 | Encephalitis (HP:0002383) | 2.84895587 |
| 75 | Agammaglobulinemia (HP:0004432) | 2.83703275 |
| 76 | Abnormality of T cells (HP:0002843) | 2.83464541 |
| 77 | Abnormality of purine metabolism (HP:0004352) | 2.80909097 |
| 78 | Purpura (HP:0000979) | 2.79610275 |
| 79 | Gout (HP:0001997) | 2.79012675 |
| 80 | Recurrent viral infections (HP:0004429) | 2.77846149 |
| 81 | Pulmonary infiltrates (HP:0002113) | 2.77112518 |
| 82 | Spontaneous hematomas (HP:0007420) | 2.75924186 |
| 83 | Epistaxis (HP:0000421) | 2.74503986 |
| 84 | Gingival bleeding (HP:0000225) | 2.73894796 |
| 85 | Autoimmune hemolytic anemia (HP:0001890) | 2.68877547 |
| 86 | Chronic diarrhea (HP:0002028) | 2.66993919 |
| 87 | Hepatocellular carcinoma (HP:0001402) | 2.66631041 |
| 88 | Increased IgE level (HP:0003212) | 2.64057975 |
| 89 | Skin nodule (HP:0200036) | 2.59508382 |
| 90 | Vascular calcification (HP:0004934) | 2.59043397 |
| 91 | Myocardial infarction (HP:0001658) | 2.57972377 |
| 92 | Inflammation of the large intestine (HP:0002037) | 2.56209028 |
| 93 | Hemoptysis (HP:0002105) | 2.55943849 |
| 94 | Increased IgM level (HP:0003496) | 2.53787516 |
| 95 | Colitis (HP:0002583) | 2.53025446 |
| 96 | Generalized aminoaciduria (HP:0002909) | 2.52623743 |
| 97 | Abnormality of T cell physiology (HP:0011840) | 2.51123337 |
| 98 | Increased serum ferritin (HP:0003281) | 2.50667329 |
| 99 | Granulocytopenia (HP:0001913) | 2.50282207 |
| 100 | Gastrointestinal inflammation (HP:0004386) | 2.49340597 |
| 101 | Hypoglycemic seizures (HP:0002173) | 2.48626031 |
| 102 | Spontaneous abortion (HP:0005268) | 2.48470964 |
| 103 | Pulmonary embolism (HP:0002204) | 2.48106633 |
| 104 | Systemic lupus erythematosus (HP:0002725) | 2.47527614 |
| 105 | Urticaria (HP:0001025) | 2.44194895 |
| 106 | Chest pain (HP:0100749) | 2.41527365 |
| 107 | Abnormal gallbladder morphology (HP:0012437) | 2.40808737 |
| 108 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.39372431 |
| 109 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.39372431 |
| 110 | Abnormality of glycolipid metabolism (HP:0010969) | 2.39372431 |
| 111 | Vomiting (HP:0002013) | 2.39293953 |
| 112 | Joint swelling (HP:0001386) | 2.39096153 |
| 113 | Malnutrition (HP:0004395) | 2.37873631 |
| 114 | Gingivitis (HP:0000230) | 2.36127007 |
| 115 | Cholelithiasis (HP:0001081) | 2.35959068 |
| 116 | Dysostosis multiplex (HP:0000943) | 2.33435098 |
| 117 | Vacuolated lymphocytes (HP:0001922) | 2.33393941 |
| 118 | Hypochromic microcytic anemia (HP:0004840) | 2.31651131 |
| 119 | Hypergammaglobulinemia (HP:0010702) | 2.31168890 |
| 120 | Abnormality of iron homeostasis (HP:0011031) | 2.31116366 |
| 121 | Cardiovascular calcification (HP:0011915) | 2.28857954 |
| 122 | Leukocytosis (HP:0001974) | 2.26747903 |
| 123 | Irritability (HP:0000737) | 2.24499087 |
| 124 | Pancreatitis (HP:0001733) | 2.24127290 |
| 125 | Recurrent bronchitis (HP:0002837) | 2.23266025 |
| 126 | Keratoconjunctivitis sicca (HP:0001097) | 2.20559094 |
| 127 | Amyloidosis (HP:0011034) | 2.20279857 |
| 128 | Enlarged kidneys (HP:0000105) | 2.20013639 |
| 129 | Neonatal onset (HP:0003623) | 2.19939020 |
| 130 | Proximal tubulopathy (HP:0000114) | 2.19710456 |
| 131 | Cellulitis (HP:0100658) | 2.18982923 |
| 132 | Skin rash (HP:0000988) | 2.18956762 |
| 133 | Spastic diplegia (HP:0001264) | 2.18833892 |
| 134 | Late onset (HP:0003584) | 2.18214462 |
| 135 | Cholecystitis (HP:0001082) | 2.17488874 |
| 136 | Abnormal gallbladder physiology (HP:0012438) | 2.17488874 |
| 137 | Acanthocytosis (HP:0001927) | 2.16222374 |
| 138 | Hyperinsulinemic hypoglycemia (HP:0000825) | 2.15984611 |
| 139 | Arterial thrombosis (HP:0004420) | 2.13074002 |
| 140 | Brushfield spots (HP:0001088) | 2.12999951 |
| 141 | Sensorimotor neuropathy (HP:0007141) | 2.12782580 |
| 142 | Gangrene (HP:0100758) | 2.12227171 |
| 143 | Glomerulonephritis (HP:0000099) | 2.09241923 |
| 144 | Anorexia (HP:0002039) | 2.07916197 |
| 145 | Esophageal varix (HP:0002040) | 2.07306692 |
| 146 | Hepatosplenomegaly (HP:0001433) | 2.05819280 |
| 147 | Keratoconjunctivitis (HP:0001096) | 2.02709344 |
| 148 | Mitral stenosis (HP:0001718) | 2.02061324 |
| 149 | Hyperuricemia (HP:0002149) | 2.00804787 |
| 150 | Increased purine levels (HP:0004368) | 2.00804787 |
| 151 | Abnormality of transition element cation homeostasis (HP:0011030) | 2.00773012 |
| 152 | Abnormality of urine glucose concentration (HP:0011016) | 2.00408466 |
| 153 | Glycosuria (HP:0003076) | 2.00408466 |
| 154 | Autoimmune thrombocytopenia (HP:0001973) | 2.00197807 |
| 155 | Opisthotonus (HP:0002179) | 1.99954160 |
| 156 | Renal cortical cysts (HP:0000803) | 1.99280752 |
| 157 | Abnormality of proline metabolism (HP:0010907) | 1.98213137 |
| 158 | Hydroxyprolinuria (HP:0003080) | 1.98213137 |
| 159 | Increased cerebral lipofuscin (HP:0011813) | 1.97424064 |
| 160 | Myoglobinuria (HP:0002913) | 1.97255420 |
| 161 | Severe combined immunodeficiency (HP:0004430) | 1.97046795 |
| 162 | Eosinophilia (HP:0001880) | 1.96607617 |
| 163 | Lymphopenia (HP:0001888) | 1.96221245 |
| 164 | Abnormality of the pleura (HP:0002103) | 1.95991028 |
| 165 | Alkalosis (HP:0001948) | 1.94902906 |
| 166 | Abnormality of the gallbladder (HP:0005264) | 1.94692229 |
| 167 | Abnormal cartilage morphology (HP:0002763) | 1.94438728 |
| 168 | Abnormality of the prostate (HP:0008775) | 1.93858890 |
| 169 | Hypochromic anemia (HP:0001931) | 1.91748909 |
| 170 | Seborrheic dermatitis (HP:0001051) | 1.90160956 |
| 171 | Rickets (HP:0002748) | 1.89651079 |
| 172 | Abnormality of vitamin metabolism (HP:0100508) | 1.88308063 |
| 173 | Acute hepatic failure (HP:0006554) | 1.88253091 |
| 174 | IgG deficiency (HP:0004315) | 1.87748252 |
| 175 | Asymmetric septal hypertrophy (HP:0001670) | 1.86280807 |
| 176 | Nausea (HP:0002018) | 1.86115962 |
| 177 | Hypertensive crisis (HP:0100735) | 1.85884950 |
| 178 | Chronic otitis media (HP:0000389) | 1.85362914 |
| 179 | Abnormality of polysaccharide metabolism (HP:0011012) | 1.84654891 |
| 180 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 1.84654891 |
| 181 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 1.84654891 |
| 182 | Menorrhagia (HP:0000132) | 1.84588258 |
| 183 | Elevated hepatic transaminases (HP:0002910) | 1.83285848 |
| 184 | Hepatic necrosis (HP:0002605) | 1.82566543 |
| 185 | Hypophosphatemic rickets (HP:0004912) | 1.81901864 |
| 186 | Thrombophlebitis (HP:0004418) | 1.79769548 |
| 187 | Acute encephalopathy (HP:0006846) | 1.79333746 |
| 188 | Hemorrhage of the eye (HP:0011885) | 1.78753154 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BCKDK | 7.86864344 |
| 2 | MAP4K1 | 4.08481033 |
| 3 | SIK1 | 4.06075618 |
| 4 | ERN1 | 3.86217142 |
| 5 | FGFR4 | 3.68818387 |
| 6 | RIPK4 | 3.33889800 |
| 7 | TXK | 3.14856832 |
| 8 | INSRR | 2.83527854 |
| 9 | FES | 2.31445233 |
| 10 | PKN2 | 2.29069554 |
| 11 | ZAP70 | 2.28314517 |
| 12 | TRIB3 | 2.14636744 |
| 13 | ERBB4 | 2.10680963 |
| 14 | JAK3 | 2.10005089 |
| 15 | TESK2 | 2.05159345 |
| 16 | TAOK3 | 2.04536790 |
| 17 | BLK | 2.04038951 |
| 18 | MST1R | 2.01828042 |
| 19 | BTK | 1.91796002 |
| 20 | PRPF4B | 1.89288025 |
| 21 | FLT3 | 1.85859312 |
| 22 | SYK | 1.83146830 |
| 23 | ITK | 1.80982883 |
| 24 | KIT | 1.80103170 |
| 25 | PIK3CG | 1.80097882 |
| 26 | PINK1 | 1.79665190 |
| 27 | TNK2 | 1.75592044 |
| 28 | IRAK4 | 1.72624905 |
| 29 | MAP2K4 | 1.63394907 |
| 30 | MAPK11 | 1.56679570 |
| 31 | TIE1 | 1.52796848 |
| 32 | KDR | 1.49927521 |
| 33 | TEC | 1.46511638 |
| 34 | EPHB1 | 1.44575067 |
| 35 | LATS1 | 1.43632965 |
| 36 | TYK2 | 1.43332356 |
| 37 | MAP2K3 | 1.40850584 |
| 38 | HCK | 1.34315085 |
| 39 | LCK | 1.34242671 |
| 40 | PTK6 | 1.32963576 |
| 41 | IKBKB | 1.32796485 |
| 42 | BMPR2 | 1.27856401 |
| 43 | MAP3K13 | 1.27587695 |
| 44 | LYN | 1.27377809 |
| 45 | FGFR2 | 1.26811236 |
| 46 | ABL2 | 1.25981015 |
| 47 | MAP3K3 | 1.22648051 |
| 48 | PRKAA2 | 1.21116378 |
| 49 | FRK | 1.20672014 |
| 50 | PDK3 | 1.16349859 |
| 51 | PDK4 | 1.16349859 |
| 52 | MAP3K7 | 1.14862714 |
| 53 | MAPKAPK3 | 1.10635879 |
| 54 | MET | 1.09415201 |
| 55 | MYLK | 1.09154111 |
| 56 | MAPK12 | 1.07063109 |
| 57 | NEK9 | 1.06132269 |
| 58 | TESK1 | 1.02402027 |
| 59 | LMTK2 | 0.99845947 |
| 60 | MAP3K1 | 0.95487597 |
| 61 | STK38L | 0.93751094 |
| 62 | PHKG1 | 0.93747909 |
| 63 | PHKG2 | 0.93747909 |
| 64 | JAK2 | 0.92255921 |
| 65 | MAPK15 | 0.90845141 |
| 66 | DAPK2 | 0.90736675 |
| 67 | OBSCN | 0.90518156 |
| 68 | TGFBR2 | 0.90049735 |
| 69 | MAPK4 | 0.89936344 |
| 70 | TBK1 | 0.88932654 |
| 71 | MAP2K6 | 0.88746658 |
| 72 | PBK | 0.84984167 |
| 73 | PIK3CA | 0.84053435 |
| 74 | GRK6 | 0.83730358 |
| 75 | CAMK2G | 0.81118663 |
| 76 | TTN | 0.80999670 |
| 77 | WNK4 | 0.80475272 |
| 78 | GRK7 | 0.79879264 |
| 79 | PDK2 | 0.75625337 |
| 80 | MARK3 | 0.75097922 |
| 81 | ERBB2 | 0.72661435 |
| 82 | TAOK1 | 0.72210661 |
| 83 | JAK1 | 0.71714151 |
| 84 | PRKACG | 0.71539304 |
| 85 | HIPK2 | 0.70024223 |
| 86 | IRAK3 | 0.69463788 |
| 87 | MATK | 0.67669634 |
| 88 | CAMKK2 | 0.67416246 |
| 89 | FGR | 0.67342140 |
| 90 | EPHA3 | 0.67092661 |
| 91 | PRKAA1 | 0.66861666 |
| 92 | GSK3A | 0.65992516 |
| 93 | MAP3K11 | 0.64970266 |
| 94 | CAMK1D | 0.64421344 |
| 95 | STK39 | 0.64174150 |
| 96 | STK10 | 0.62331815 |
| 97 | CDC42BPA | 0.62045335 |
| 98 | MAP2K2 | 0.61262096 |
| 99 | PRKCZ | 0.60579982 |
| 100 | SIK3 | 0.58612870 |
| 101 | RIPK1 | 0.58455632 |
| 102 | PDPK1 | 0.56846737 |
| 103 | PRKCQ | 0.56204875 |
| 104 | OXSR1 | 0.55729773 |
| 105 | FGFR3 | 0.55717707 |
| 106 | MAP3K14 | 0.55553313 |
| 107 | GRK1 | 0.55225085 |
| 108 | CSK | 0.53569934 |
| 109 | TRPM7 | 0.52947424 |
| 110 | MAPK7 | 0.52106811 |
| 111 | PRKD2 | 0.50937744 |
| 112 | SGK223 | 0.50890398 |
| 113 | SGK494 | 0.50890398 |
| 114 | MAP3K12 | 0.50566008 |
| 115 | MAPKAPK2 | 0.49510678 |
| 116 | FYN | 0.48470537 |
| 117 | SMG1 | 0.48383361 |
| 118 | PRKD1 | 0.47659176 |
| 119 | PIM1 | 0.47218692 |
| 120 | PKN1 | 0.45110719 |
| 121 | SGK3 | 0.44107924 |
| 122 | MAP2K1 | 0.43408051 |
| 123 | CDK6 | 0.42422944 |
| 124 | IRAK1 | 0.42088646 |
| 125 | IKBKE | 0.41427612 |
| 126 | SCYL2 | 0.41329775 |
| 127 | CAMKK1 | 0.41326816 |
| 128 | DYRK1B | 0.41307468 |
| 129 | IRAK2 | 0.40654485 |
| 130 | PRKG2 | 0.40191594 |
| 131 | IGF1R | 0.39913720 |
| 132 | TLK1 | 0.39544519 |
| 133 | PAK3 | 0.38039039 |
| 134 | PTK2B | 0.37767900 |
| 135 | MAP3K6 | 0.37296603 |
| 136 | CSF1R | 0.36961967 |
| 137 | EPHB2 | 0.36844899 |
| 138 | PIM2 | 0.36070044 |
| 139 | TAOK2 | 0.35617108 |
| 140 | MAP3K5 | 0.34472254 |
| 141 | PRKCD | 0.34298733 |
| 142 | SGK2 | 0.33718813 |
| 143 | CAMK4 | 0.32717803 |
| 144 | CSNK1G1 | 0.31890088 |
| 145 | NME2 | 0.31184742 |
| 146 | RPS6KC1 | 0.30772724 |
| 147 | RPS6KL1 | 0.30772724 |
| 148 | NLK | 0.30674018 |
| 149 | RET | 0.30522234 |
| 150 | PDK1 | 0.30505443 |
| 151 | LRRK2 | 0.29586503 |
| 152 | PTK2 | 0.29166326 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 8.37131321 |
| 2 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 4.11697180 |
| 3 | Nitrogen metabolism_Homo sapiens_hsa00910 | 3.34694991 |
| 4 | Allograft rejection_Homo sapiens_hsa05330 | 3.32171745 |
| 5 | Graft-versus-host disease_Homo sapiens_hsa05332 | 3.27019098 |
| 6 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 3.23555592 |
| 7 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 3.21585128 |
| 8 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 3.09660716 |
| 9 | Primary immunodeficiency_Homo sapiens_hsa05340 | 3.05325128 |
| 10 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.80810899 |
| 11 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.74189440 |
| 12 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.71815667 |
| 13 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.70896838 |
| 14 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.68749315 |
| 15 | Asthma_Homo sapiens_hsa05310 | 2.62658938 |
| 16 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.61556234 |
| 17 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 2.47982117 |
| 18 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 2.47411913 |
| 19 | Propanoate metabolism_Homo sapiens_hsa00640 | 2.38159951 |
| 20 | Antigen processing and presentation_Homo sapiens_hsa04612 | 2.37606408 |
| 21 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.37593559 |
| 22 | Other glycan degradation_Homo sapiens_hsa00511 | 2.37057558 |
| 23 | Leishmaniasis_Homo sapiens_hsa05140 | 2.30498025 |
| 24 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 2.30107505 |
| 25 | Butanoate metabolism_Homo sapiens_hsa00650 | 2.28522959 |
| 26 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.25854981 |
| 27 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 2.19328940 |
| 28 | * Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 2.11055716 |
| 29 | * Peroxisome_Homo sapiens_hsa04146 | 2.10498217 |
| 30 | Fatty acid metabolism_Homo sapiens_hsa01212 | 2.04958989 |
| 31 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.94526319 |
| 32 | * Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.88045757 |
| 33 | * Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.87239190 |
| 34 | Histidine metabolism_Homo sapiens_hsa00340 | 1.86039711 |
| 35 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.84208901 |
| 36 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.83544627 |
| 37 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.81600177 |
| 38 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.77990927 |
| 39 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.76906770 |
| 40 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.75603911 |
| 41 | Viral myocarditis_Homo sapiens_hsa05416 | 1.75504757 |
| 42 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.69206899 |
| 43 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.63800982 |
| 44 | Retinol metabolism_Homo sapiens_hsa00830 | 1.62561252 |
| 45 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.61519204 |
| 46 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.59405224 |
| 47 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.58567097 |
| 48 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.57964705 |
| 49 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.57237845 |
| 50 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.54849901 |
| 51 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.51540333 |
| 52 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.50379125 |
| 53 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.44217469 |
| 54 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.43930551 |
| 55 | Bile secretion_Homo sapiens_hsa04976 | 1.40732727 |
| 56 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.40332124 |
| 57 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.37946771 |
| 58 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.36753427 |
| 59 | Tuberculosis_Homo sapiens_hsa05152 | 1.36515567 |
| 60 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.34497440 |
| 61 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.32295521 |
| 62 | Carbon metabolism_Homo sapiens_hsa01200 | 1.31215936 |
| 63 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.30449923 |
| 64 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.28182843 |
| 65 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.26292610 |
| 66 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.25391180 |
| 67 | Measles_Homo sapiens_hsa05162 | 1.21854356 |
| 68 | Steroid biosynthesis_Homo sapiens_hsa00100 | 1.21848067 |
| 69 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.19871125 |
| 70 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.19256582 |
| 71 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.16158661 |
| 72 | Pertussis_Homo sapiens_hsa05133 | 1.15733062 |
| 73 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.13833869 |
| 74 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.11459747 |
| 75 | Malaria_Homo sapiens_hsa05144 | 1.08234478 |
| 76 | Influenza A_Homo sapiens_hsa05164 | 1.07843112 |
| 77 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 1.07529303 |
| 78 | ABC transporters_Homo sapiens_hsa02010 | 1.06661522 |
| 79 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.04464264 |
| 80 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.03538605 |
| 81 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.03475640 |
| 82 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.03198615 |
| 83 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.99519107 |
| 84 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.99438024 |
| 85 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.96299410 |
| 86 | Sulfur relay system_Homo sapiens_hsa04122 | 0.94664369 |
| 87 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.94656000 |
| 88 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.94135934 |
| 89 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.91021025 |
| 90 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.90571379 |
| 91 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.87220587 |
| 92 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.85200346 |
| 93 | Lysosome_Homo sapiens_hsa04142 | 0.85192152 |
| 94 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.84930113 |
| 95 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.84878455 |
| 96 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.79613306 |
| 97 | Platelet activation_Homo sapiens_hsa04611 | 0.79399144 |
| 98 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.79073242 |
| 99 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.78208121 |
| 100 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.77100754 |
| 101 | Lysine degradation_Homo sapiens_hsa00310 | 0.75276022 |
| 102 | * Glutathione metabolism_Homo sapiens_hsa00480 | 0.75196367 |
| 103 | Phagosome_Homo sapiens_hsa04145 | 0.74146943 |
| 104 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.73024684 |
| 105 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.70192525 |
| 106 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.69959682 |
| 107 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.69853573 |
| 108 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.68234685 |
| 109 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.64659964 |
| 110 | Legionellosis_Homo sapiens_hsa05134 | 0.62205172 |
| 111 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.60818290 |
| 112 | Metabolic pathways_Homo sapiens_hsa01100 | 0.53181611 |
| 113 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.51384025 |
| 114 | Apoptosis_Homo sapiens_hsa04210 | 0.42259995 |
| 115 | Shigellosis_Homo sapiens_hsa05131 | 0.40439614 |
| 116 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.38844255 |
| 117 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.38171534 |
| 118 | Galactose metabolism_Homo sapiens_hsa00052 | 0.35783165 |
| 119 | Salmonella infection_Homo sapiens_hsa05132 | 0.34454008 |
| 120 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.34111944 |
| 121 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.33342265 |
| 122 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.32849597 |
| 123 | Hepatitis B_Homo sapiens_hsa05161 | 0.31343172 |
| 124 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.28991430 |
| 125 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.27526796 |
| 126 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.25549116 |
| 127 | Insulin resistance_Homo sapiens_hsa04931 | 0.25209640 |
| 128 | Prion diseases_Homo sapiens_hsa05020 | 0.21848265 |
| 129 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.15729447 |
| 130 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.07482786 |
| 131 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.05562879 |
| 132 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.05059624 |
| 133 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | -0.2356494 |
| 134 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | -0.2260442 |
| 135 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | -0.1973684 |
| 136 | African trypanosomiasis_Homo sapiens_hsa05143 | -0.1845759 |
| 137 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | -0.1813191 |
| 138 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | -0.1812334 |
| 139 | Hepatitis C_Homo sapiens_hsa05160 | -0.1788967 |
| 140 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | -0.1787198 |
| 141 | Regulation of autophagy_Homo sapiens_hsa04140 | -0.1584144 |
| 142 | Mineral absorption_Homo sapiens_hsa04978 | -0.1552583 |
| 143 | Protein digestion and absorption_Homo sapiens_hsa04974 | -0.1307190 |
| 144 | Ether lipid metabolism_Homo sapiens_hsa00565 | -0.1069328 |
| 145 | Renin-angiotensin system_Homo sapiens_hsa04614 | -0.1008992 |
| 146 | Insulin signaling pathway_Homo sapiens_hsa04910 | -0.0999000 |
| 147 | Alzheimers disease_Homo sapiens_hsa05010 | -0.0736455 |
| 148 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | -0.0717965 |
| 149 | Parkinsons disease_Homo sapiens_hsa05012 | -0.0156905 |
| 150 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | -0.0108411 |

